Regarding serum I-FABP, multiple studies have shown that serum I-FABP levels in infants with NEC stage III are significantly higher than those in the healthy control group and infants with stage I/II (P < 0.05) (80–82). This evidence concerns the gene FABP2 and necrotizing enterocolitis.